/ Report Details / Atrial Fibrillation Market

Atrial Fibrillation Market, By Procedure (Pharmacological Drugs [Anti-arrhythmic, Anti-coagulant], Non-Pharmacological Treatment [Catheter Ablation Procedures, Maze Surgery, Electric Cardioversion]) and By Geography (EU, NA, APAC, LATAM, and MEA) Analysis, Size, Share, Trends, & Forecast from 2020-2026

Report Code: AV611

Industry: Healthcare

Publiced On: 2020-05-01

Pages: 177

Format: ppt pdf

REPORT HIGHLIGHT

Atrial fibrillation market was valued at USD 14.38 billion by 2019, growing with 14.9% CAGR during the forecast period, 2020-2026.

Atrial fibrillation is an irregular or rapid rhythm of the heart, which increases the risk of stroke, heart, blood clots, and other complications. In atrial fibrillation, the upper chambers of the heartbeats irregularly in a very rapid pattern, which results in slowing down of blood flow. The complications of atrial fibrillation include pressure, angina, or chest pain that leads to congestive heart failure. Fainting, fatigue, dizziness, and confusion are some of the symptoms of atrial fibrillation.

Market Dynamics

The growing prevalence of atrial fibrillation along with the increasing geriatric population is a major factor driving the growth of the global atrial fibrillation market. In addition, the growing incidence rates of atrial fibrillation causing diseases such as high blood pressure, mitral stenosis, pulmonary embolus, hyperthyroidism, obesity, and pneumonia is one of the notable factors responsible for the growing prevalence of this disorder. According to the World Health Organization (WHO), about 11% of the population aged 75 years and above all across the globe, suffer from atrial fibrillation. Furthermore, the rise in medical tourism coupled with the rising preference of catheter ablation for treating cardiac arrhythmia will propel the industry growth further. Conversely, the unfavorable inclination towards pharmaceutical drugs over atrial fibrillation, high costs associated with the devices, and lack of skilled professionals are expected to hamper the market growth in the coming future. On the contrary, the rising need for minimally invasive procedures and technological advancements are predicted to create lucrative growth opportunities in the overall market during the forecast period.

Procedure Takeaway

Based on the procedure, the worldwide market for atrial fibrillation is categorized into pharmacological drugs and non-pharmacological treatments. The pharmacological drugs segment includes anticoagulation and antiarrhythmic drugs. Further, the non-pharmacological treatment segment is sub-categorized into electric cardioversion, maze surgery, and the catheter ablation procedures into HIFU, radiofrequency, laser, microwave, and cryoablation. Among these, the catheter ablation surgical devices are the most commonly used for treating cardiac arrhythmias. These surgical devices are also used for the treatment of atrial fibrillation when anti-coagulant drugs and other medications are not tolerated or administered by the patient. Thus, the catheter ablation segment is estimated to dominate the market in terms of revenue in the forecast period. Moreover, an increase in the adoption rate of the catheter ablation system is expected to increase steadily, owing to the growing procedural success rate in patients that suffer from permanent, persistent, and paroxysmal conditions of atrial fibrillation.

Among the surgical catheter ablation, microwave and radiofrequency are the most commonly used catheter ablation procedures. The faster recovery rate of these procedures and the decreased size of the cardiac incision are other factors contributing to the segmental market growth.

Regional Takeaway

Regionally, the global industry is divided into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The North America region accounted for the majority of share in 2019 and is estimated to dominate the industry during the forecast period. This dominance is majorly attributed to the growing adoption of technological advancements and the presence of sophisticated healthcare infrastructure. In addition, the governments of several countries and market players are investing more in atrial fibrillation procedures, which is anticipated to boost the regional market growth.

On the other hand, the Asia Pacific market for atrial fibrillation is anticipated to witness the fastest growth during the forecast period. This is mainly owing to the vast population and various age groups being vulnerable to cardiac diseases. Besides, the rising demand for atrial fibrillation devices and improving healthcare infrastructure are predicted to propel the growth of the Asia Pacific region.

COVID-19 Impact

The sudden outbreak of the COVID-19 pandemic has immensely affected the global atrial fibrillation market. The key players of the industry have built and broken various value-grab opportunities to sustain in these trying times. They are capitalizing on novel strategies to obtain and maintain a stable revenue income. However, the global market is estimated to recover soon after the coronavirus chaos.

Key Vendor Takeaway

The leading players of the global atrial fibrillation market include Sanofi-Aventis, AtriCure Inc., Biosense Webster Inc., CardioFocus Inc., Bristol-Myers Squibb Corporation, Boston Scientific Corporation, Endoscopic Technologies Inc., Johnson & Johnson Ltd., St. Jude Medical Inc., and Boehringer Ingelheim GmbH. These players are implementing various strategies such as mergers, acquisitions, and technological advancements to hold a strong position in the global industry.

For instance, in August 2019, a leading innovator in treatments for left atrial appendage (LAA) and atrial fibrillation, AtriCure, Inc. acquired SentreHEART by entering into an agreement. The company’s aim behind this acquisition is to provide better atrial fibrillation treatment and expand their business.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year – 2015 to2018
  • Base Year – 2019
  • Estimated Year – 2020
  • Projected Year – 2026

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

  • Sanofi-Aventis
  • AtriCure Inc.
  • Biosense Webster Inc.
  • CardioFocus Inc.
  • Bristol-Myers Squibb Corporation
  • Boston Scientific Corporation
  • Endoscopic Technologies Inc.
  • Johnson & Johnson Ltd.
  • Jude Medical Inc.
  • Boehringer Ingelheim GmbH

ATRIAL FIBRILLATION MARKET, BY PROCEDURE

  • Pharmacological Drugs
    • Anti-arrhythmic Drugs
    • Anticoagulant Drugs
  • Non-Pharmacological Treatment
    • Catheter Ablation Procedures
      • HIFU
      • Radiofrequency
      • Laser
      • Microwave
      • Cryoablation
    • Maze Surgery
    • Electric Cardioversion

ATRIAL FIBRILLATION MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Singapore
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Rest of MEA

TABLE OF CONTENT

1. ATRIAL FIBRILLATION MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Procedure
2.1.2. Market Snippet by Region
2.2. Competitive Insights
3. ATRIAL FIBRILLATION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. ATRIAL FIBRILLATION INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. ATRIAL FIBRILLATION MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. ATRIAL FIBRILLATION MARKET – BY PROCEDURE
6.1. Overview
6.1.1. Segment Share Analysis, By Procedure, 2019 & 2026 (%)
6.2. Pharmacological Drugs
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.2.2.1. Anti-coagulant Drugs
6.2.2.1.1. Overview
6.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.2.2.2. Anti-arrhythmic Drugs
6.2.2.2.1. Overview
6.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Non-Pharmacological Treatment
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1. Catheter Ablation Procedures
6.3.2.1.1. Overview
6.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1.2.1. HIFU
6.3.2.1.2.1.1. Overview
6.3.2.1.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1.2.2. Radiofrequency
6.3.2.1.2.2.1. Overview
6.3.2.1.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1.2.3. Laser
6.3.2.1.2.3.1. Overview
6.3.2.1.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1.2.4. Microwave
6.3.2.1.2.4.1. Overview
6.3.2.1.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.1.2.3.5. Cryoablation
6.3.2.1.2.4.3. Overview
6.3.2.1.2.4.4. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.2. Maze Surgery
6.3.2.2.1. Overview
6.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3.2.3. Electric Cardioversion
6.3.2.3.1. Overview
6.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)

7. ATRIAL FIBRILLATION MARKET– BY GEOGRAPHY
7.1. Introduction
7.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
7.2. North America
7.2.1. Overview
7.2.2. Key Manufacturers in North America
7.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
7.2.4. North America Market Size and Forecast, By Procedure, 2015 – 2026 (US$ Million)
7.2.5. U.S.
7.2.5.1. Overview
7.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.2.6. Canada
7.2.6.1. Overview
7.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Europe
7.3.1. Overview
7.3.2. Key Manufacturers in Europe
7.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
7.3.4. Europe Market Size and Forecast, By Procedure, 2015 – 2026 (US$ Million)
7.3.5. Germany
7.3.5.1. Overview
7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.6. Italy
7.3.6.1. Overview
7.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.7. United Kingdom
7.3.7.1. Overview
7.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.8. France
7.3.8.1. Overview
7.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3.9. Rest of Europe
7.3.9.1. Overview
7.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Asia Pacific (APAC)
7.4.1. Overview
7.4.2. Key Manufacturers in Asia Pacific
7.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
7.4.4. Asia Pacific Market Size and Forecast, By Procedure, 2015 – 2026 (US$ Million)
7.4.5. India
7.4.5.1. Overview
7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4.6. China
7.4.6.1. Overview
7.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4.7. Japan
7.4.7.1. Overview
7.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4.8. South Korea
7.4.8.1. Overview
7.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4.9. Rest of APAC
7.4.9.1. Overview
7.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Latin America
7.5.1. Overview
7.5.2. Key Manufacturers in Latin America
7.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
7.5.4. Latin America Market Size and Forecast, By Procedure, 2015 – 2026 (US$ Million)
7.5.5. Brazil
7.5.5.1. Overview
7.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5.6. Mexico
7.5.6.1. Overview
7.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5.7. Argentina
7.5.7.1. Overview
7.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5.8. Rest of LATAM
7.5.8.1. Overview
7.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6. Middle East and Africa
7.6.1. Overview
7.6.2. Key Manufacturers in Middle East and Africa
7.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
7.6.4. Middle East and Africa Market Size and Forecast, By Procedure, 2015 – 2026 (US$ Million)
7.6.5. Saudi Arabia
7.6.5.1. Overview
7.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6.6. United Arab Emirates
7.6.6.1. Overview
7.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. KEY VENDOR ANALYSIS
8.1. Sanofi-Aventis
8.1.1. Company Snapshot
8.1.2. Financial Performance
8.1.3. Procedure Benchmarking
8.1.4. Strategic Initiatives
8.2. AtriCure Inc.
8.3. Biosense Webster Inc.
8.4. CardioFocus Inc.
8.5. Bristol-Myers Squibb Corporation
8.6. Boston Scientific Corporation
8.7. Endoscopic Technologies Inc.
8.8. Johnson & Johnson Ltd.
8.9. St. Jude Medical Inc.
8.10. Boehringer Ingelheim GmbH.
9. 360 DEGREE ANALYSTVIEW
10. APPENDIX
10.1. Research Methodology
10.2. References
10.3. Abbreviations
10.4. Disclaimer
10.5. Contact Us

List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Atrial Fibrillation market: ProcedureSnapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Procedure
TABLE Global Atrial Fibrillation market, by Procedure2015-2026 (USD Million)
TABLE Atrial Fibrillation market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Atrial Fibrillation market, by Region 2015-2026 (USD Million)
TABLE North America Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
TABLE North America Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
TABLE Europe Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
TABLE Europe Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
TABLE Asia Pacific Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
TABLE Asia Pacific Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
TABLE Latin America Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
TABLE Latin America Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
TABLE Middle East and Africa Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
TABLE Middle East and Africa Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)

List of Figures
FIGURE Atrial Fibrillation market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Procedure segment market share analysis, 2019 & 2026
FIGURE Procedure segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Pharmacological Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Anti-coagulant Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Anti-arrhythmic Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Non-Pharmacological Treatment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Catheter Ablation Procedures market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Maze Surgery market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Electric Cardioversion Implants market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE HIFU market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Radiofrequency market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Laser market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Microwave market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cryoablation market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Atrial Fibrillation market share and leading players, 2018
FIGURE Europe Atrial Fibrillation market share and leading players, 2018
FIGURE Asia Pacific Atrial Fibrillation market share and leading players, 2018
FIGURE Latin America Atrial Fibrillation market share and leading players, 2018
FIGURE Middle East and Africa Atrial Fibrillation market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Atrial Fibrillation market share analysis by country, 2018
FIGURE Germany Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Atrial Fibrillation market share analysis by country, 2018
FIGURE India Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Atrial Fibrillation market share analysis by country, 2018
FIGURE Brazil Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Atrial Fibrillation market share analysis by country, 2018
FIGURE Saudi Arabia Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights